Search Results - "Mentze, M."
-
1
Role of serum concentration of VEGFR1 and TIMP2 on clinical outcome in primary cervical cancer: Results of a companion protocol of the randomized, NOGGO–AGO phase III adjuvant trial of simultaneous cisplatin-based radiochemotherapy vs. carboplatin and paclitaxel containing sequential radiotherapy
Published in Cytokine (Philadelphia, Pa.) (01-03-2013)“…► VEGFR1, TIMP2 and MMP2 had impact on surgical outcome in primary cervical cancer. ► VEGFR1 correlated with lymph node status. ► TIMP2 independent prognostic…”
Get full text
Journal Article -
2
Role of serum concentration of VEGFR1 and TIMP2 on clinical outcome in primary cervical cancer: Results of a companion protocol of the randomized, NOGGOaAGO phase III adjuvant trial of simultaneous cisplatin-based radiochemotherapy vs. carboplatin and paclitaxel containing sequential radiotherapy
Published in Cytokine (Philadelphia, Pa.) (01-03-2013)“…Objective: Aim of the present study was to analyze the expression-profile of IGF1, IGFBP3, sICAM1, sVCAM1, MMP2, MMP9, TIMP2, VEGFA, VEGFD, VEGFC and VEGFR1 in…”
Get full text
Journal Article -
3
Does overexpression of VEGFR and TIMP2 predict survival in primary cervical cancer (CC) patients? Results of a companion protocol of the randomized, phase III adjuvant trial of simultaneous cisplatin radiochemotherapy versus sequential carboplatin and paclitaxel followed by radiotherapy
Published in Journal of clinical oncology (20-05-2011)“…Abstract only…”
Get full text
Journal Article -
4
HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer - a study of the OVCAD Consortium
Published in OncoTargets and therapy (11-09-2014)“…Hypoxia is a common phenomenon encountered in solid cancers, leading to chemotherapy resistance and therefore to aggressiveness of the disease. The homeostatic…”
Get full text
Journal Article